Rinofrenal Rhinological Solution 15ml,Rinofrenal Soluzione Rinologica 15ml,TEOFARMA LTD

“ACTIVE ingredients: Sodium cromoglycate, chlorphenamine maleate. Excipients: Sodium phosphate, sodium phosphate sodium monohydrate, methyl-p-idrossibe nzoato, sodium edetate, propylparaben p-hydroxybenzoate, distilled water.
INDICATIONS: the drug is indicated for the treatment of symptoms of acute allergic rhinitis, seasonal and perennial.
CONTRAINDICATIONS/EFF.SECONDARY: Hypersensitivity to the active or any of the excipients.
DOSAGE: 1-2 sprays in each nostril 3-4 times a day; do not exceed the dose of the advisor. After elimination of acute rinitic symptoms, it is advisable to continue treatment with a drug based only on sodium cromoglycate in order to prevent the appearance of symptoms.
STORAGE: No special storage measures are provided.
Special INSTRUCTIONS: If the drug is taken in high doses. Specialty’ va u sata with caution in the elderly, in persons with a medical history of hypertrophy in the prostate and glaucoma, as well as in the case of peptic ulcer formation of structures and obstruction of the bladder neck. Use with caution even in cases of liver failure. The drug 4% + 0.2% nasal spray, solution of conte methyl p-hydroxybenzoic and propyl p-hydroxybenzoic, which I may not, cause allergic reactions (possibly of a delayed type).
INTERACTIONS: None known.
SIDE EFFECTS: Although I am not with the medicine you, if it has happened so far, please keep in mind, you, however, that as a result of the administration of sodium cromoglicat or powder for inhalation, some effects have been reported c ollat which phenomena of non-specific irritation due to pri me respiratory paths are widely represented velle pharynx, cough, t ransitori episodes of bronchospasticity that recede, easily, and they can es sere be prevented by administering bronchodilators. If high doses are taken, sistem ici effects from antihistamines, such as sedation and drowsiness, may occur. Very rarely, I know of, no undesirable effects have been described, including nausea, cefal ea, urticaria, angioedema, myalgia, arthralgia, eosinophilic infiltrates p olmonari and intense episodes of bronchospasticity, which may occur before or during therapy. Such manifestations require discontinuation of treatment measures.
PREGNANCY AND BREAST-FEEDING: In pregnant women, the product should be prescribed only if necessary and under the supervision of a physician.”